Pivotal Response Treatment for Individuals With Intellectual Disabilities
- Conditions
- Speech DelayIntellectual DisabilitiesLanguage Disorder
- Registration Number
- NCT01988623
- Lead Sponsor
- Stanford University
- Brief Summary
The investigators will assess the efficacy of Pivotal Response Treatment (PRT) in the treatment of communication deficits in children with intellectual disabilities. By collecting information about parent and child functioning before and after PRT, The investigators will be able to determine whether the intervention is effective in improving child communication and reducing parent stress.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 21
Not provided
- medically unstable (such as having unstable seizures)
- primary diagnosis of Autism Spectrum Disorder (ASD) is exclusionary as determined by the investigators
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Change from Baseline on the Social Responsiveness Scale (SRS) at 6, 12, and 24 weeks 6, 12 and 24 weeks Change from Baseline on the Clinical Global Impression Scale at 6, 12, and 24 weeks 6, 12, and 24 weeks Change from Baseline on the MacArthur-Bates Communication Development Inventory at 6, 12, and 24 weeks 6, 12 and 24 weeks Change from Baseline in communication during parent-child and clinician-child interactions at 6, 12, and 24 weeks 6, 12 and 24 weeks
- Secondary Outcome Measures
Name Time Method Change from Baseline on the Vineland Adaptive Behavior Scales, Second Edition (VABS-II) at 6, 12, and 24 weeks 6, 12 and 24 weeks Change from Baseline on the Parenting Stress Index (PSI) at 6, 12, and 24 weeks 6, 12, and 24 weeks Change from Baseline on the Family Empowerment Scale (FES) at 6, 12, and 24 weeks 6, 12, and 24 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Stanford University School of Medicine
🇺🇸Stanford, California, United States
Stanford University School of Medicine🇺🇸Stanford, California, United States